神经调控医疗技术
Search documents
分论坛:中国医药的全球价值时刻|国泰海通“远望又新峰”2026春季策略会
国泰海通证券研究· 2026-03-18 09:13
Group 1 - The article discusses the upcoming Guotai Haitong Spring Strategy Conference scheduled for March 25, 2026, in Shenzhen, focusing on innovative breakthroughs and global value opportunities [1] - Key topics include the exploration of long-term precise weight loss and metabolic benefits through a new generation RNAi technology platform, presented by Meng Na, Vice President of Capital Markets at Saint Gene Biotech [1] - Other presentations will cover applications and prospects of brain-machine interfaces and neuro-regulation medical technologies, as well as advancements in lipid management through small nucleic acid drugs, presented by industry experts [1]